• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙下阿拉贡地区多发性硬化症的患病率和发病率趋势。

Trends in prevalence and incidence of multiple sclerosis in Bajo Aragón, Spain.

作者信息

Modrego Pedro J, Pina Miguel A

机构信息

Neurology Unit, Hospital de la Seguridad Social de Alcañiz, 44600, Alcañiz, Spain.

出版信息

J Neurol Sci. 2003 Dec 15;216(1):89-93. doi: 10.1016/j.jns.2003.07.007.

DOI:10.1016/j.jns.2003.07.007
PMID:14607307
Abstract

OBJECTIVE

Recent reports provide consistent evidence that Spain is an area of high risk for multiple sclerosis (MS) according to prevalence surveys. However, the studies of incidence are scarce. The objective of the current work is to analyse whether the increased prevalence of MS is accompanied by increasing incidence in the area of Bajo Aragón, northeastern Spain.

METHODS

The data of both prevalence and incidence were retrieved from a prospective register created in 1994 and which included patients with probable or definite MS. Crude and age-standardised rates were calculated from 1994 to 2002 and compared with those found retrospectively in the previous period of 1984-1993.

RESULTS

In January 2003, we found a prevalence rate of 75/100,000 (95% CI: 52-97) whereas it was 35/100,000 (95% CI: 20-50) in 1994. In a period of 9 years, 25 new cases were diagnosed in the area with a mean annual incidence rate of 4.6/100,000 (95% CI: 2.8-6.5; range: 1.6-13.6) in comparison to 17 new cases from 1984 to 1993 with a mean incidence rate of 3/100,000 (95% CI: 1.6-4.5). The standardised ratio of incidences was 1.44 (95% CI: 0.95-2.17) and, therefore, the difference of rates was not significant.

CONCLUSION

We conclude that the increase in prevalence of MS is more likely to be due to improvement on case ascertainment than to increasing incidence. Nonetheless, further prospective incidence studies in larger populations are warranted in Spain to elucidate whether the frequency of this disease is truly increasing.

摘要

目的

近期报告提供了一致的证据,根据患病率调查,西班牙是多发性硬化症(MS)的高风险地区。然而,发病率的研究却很少。当前这项工作的目的是分析西班牙东北部阿拉贡低地地区MS患病率的增加是否伴随着发病率的上升。

方法

患病率和发病率数据均取自1994年创建的前瞻性登记册,该登记册纳入了可能或确诊为MS的患者。计算了1994年至2002年的粗率和年龄标准化率,并与1984 - 1993年前期回顾性研究中的数据进行比较。

结果

2003年1月,我们发现患病率为75/100,000(95%可信区间:52 - 97),而1994年为35/100,000(95%可信区间:20 - 50)。在9年时间里,该地区诊断出25例新病例,年平均发病率为4.6/100,000(95%可信区间:2.8 - 6.5;范围:1.6 - 13.6),相比之下,1984年至1993年有17例新病例,平均发病率为3/100,000(95%可信区间:1.6 - 4.5)。发病率的标准化比率为1.44(95%可信区间:0.95 - 2.17),因此,发病率差异不显著。

结论

我们得出结论,MS患病率的增加更可能是由于病例确诊的改善,而非发病率上升。尽管如此,西班牙仍有必要在更大规模人群中开展进一步的前瞻性发病率研究,以阐明这种疾病的发病率是否真的在增加。

相似文献

1
Trends in prevalence and incidence of multiple sclerosis in Bajo Aragón, Spain.西班牙下阿拉贡地区多发性硬化症的患病率和发病率趋势。
J Neurol Sci. 2003 Dec 15;216(1):89-93. doi: 10.1016/j.jns.2003.07.007.
2
Prevalence of multiple sclerosis in the province of Teruel, Spain.西班牙特鲁埃尔省多发性硬化症的患病率。
J Neurol. 1997 Mar;244(3):182-5. doi: 10.1007/s004150050070.
3
Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain.西班牙加那利群岛拉斯帕尔马斯多发性硬化症的患病率和发病率
Neuroepidemiology. 2005;24(1-2):70-5. doi: 10.1159/000081052. Epub 2004 Sep 24.
4
Multiple sclerosis in Móstoles, central Spain.西班牙中部莫斯托莱斯的多发性硬化症。
Acta Neurol Scand. 1998 Oct;98(4):238-42. doi: 10.1111/j.1600-0404.1998.tb07302.x.
5
Multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕的多发性硬化症
Int Rev Neurobiol. 2007;79:357-75. doi: 10.1016/S0074-7742(07)79016-5.
6
Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).圣地亚哥-德孔波斯特拉(西班牙)多发性硬化症的流行病学。
Acta Neurol Scand. 2020 Sep;142(3):267-274. doi: 10.1111/ane.13265. Epub 2020 May 26.
7
Epidemiological study of multiple sclerosis in La Rioja.拉里奥哈地区多发性硬化症的流行病学研究。
Neurologia. 2015 Nov-Dec;30(9):552-60. doi: 10.1016/j.nrl.2014.04.016. Epub 2014 Jun 26.
8
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.爱尔兰共和国多发性硬化症的发病率:一项前瞻性基于人群的研究。
Mult Scler Relat Disord. 2017 Apr;13:75-80. doi: 10.1016/j.msard.2017.02.010. Epub 2017 Feb 14.
9
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.挪威西部霍达兰郡多发性硬化症发病率和患病率的60年随访研究。
J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.
10
Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.希腊西部多发性硬化症的患病率和发病率:一项为期23年的调查。
Neuroepidemiology. 2008;30(3):167-73. doi: 10.1159/000122334. Epub 2008 Apr 2.

引用本文的文献

1
Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.系统文献回顾和荟萃分析美国、欧洲、加拿大、澳大利亚和巴西的继发进展性多发性硬化症的患病率。
BMC Neurol. 2022 Aug 17;22(1):301. doi: 10.1186/s12883-022-02820-0.
2
Relationship between optical coherence tomography angiography and visual evoked potential in patients with multiple sclerosis.多发性硬化症患者光学相干断层扫描血管造影与视觉诱发电位的关系。
Indian J Ophthalmol. 2022 Mar;70(3):873-878. doi: 10.4103/ijo.IJO_431_21.
3
Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
伊朗多发性硬化症发病率的急剧上升趋势是真实的吗?
BMC Neurol. 2021 Jan 7;21(1):7. doi: 10.1186/s12883-020-02031-5.
4
Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance.患者 8 种特定罕见病的医疗服务保障:来自中国医保患者医疗服务利用国家体系的证据。
Orphanet J Rare Dis. 2019 Aug 20;14(1):204. doi: 10.1186/s13023-019-1165-7.
5
Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.AS03佐剂的甲型H1N1流感大流行病毒和H5N1流感病毒灭活裂解疫苗在成人中的安全性:28项临床试验的汇总分析
Hum Vaccin Immunother. 2014;10(10):2942-57. doi: 10.4161/21645515.2014.972149. Epub 2014 Nov 21.
6
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.欧洲多发性硬化症的发病率和患病率:系统评价。
BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128.
7
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.1985-2009 年欧洲经济区人群多发性硬化症发病率:监测框架。
BMC Neurol. 2013 Jun 12;13:58. doi: 10.1186/1471-2377-13-58.
8
Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study.AS03 佐剂季节性流感病毒裂解疫苗(H1N1)(2009 年)的安全性:一项前瞻性队列研究。
BMJ Open. 2013 Feb 5;3(2). doi: 10.1136/bmjopen-2012-001912. Print 2013.
9
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.